Northrop Grumman’s Q1 2026 10-Q disclosed a remaining $1 billion loss accrual tied to the B-21 Raider low-rate initial production (LRIP), reflecting ongoing challenges in cost management amid advanced aircraft manufacturing. Simultaneously, the company finalized an agreement with the U.S. Air Force to increase production rates by selling a planned test aircraft, signaling commitment to scaling capacity. With roughly 84% of sales dependent on U.S. government contracts across diversified aerospace and defense segments, Northrop maintains a robust backlog (~$95.7 billion) underpinning revenue visibility. While geopolitical tensions and heightened defense spending support growth, exposure to program execution risk, supply chain volatility, and regulatory scrutiny present ongoing operational constraints.